UNSPSC 51391732: Octopamine

This classification denotes an alpha-adrenergic agonist with the molecular formula C8H11NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 14O50WS8JD, chemically known as benzyl alcohol, .alpha.- (aminomethyl)-p-hydroxy-, hydrochloride, (.+-.)- but generally known as octopamine, which bears US NIH Compound Identifier 4581. European Medicines Agency schedules Octopamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09415MIG.

UNSPSC 51391732 Octopamine, a Commodity code, shows minimal recent state and local procurement activity aligned with its nominal pharmaceutical scope. The two recent opportunities tagged to this code reflect acute misalignment: Seminole County, Florida is purchasing naloxone and drug deactivation systems for community health initiatives (an opioid-response product category), and the Texas Health and Human Services Commission issued a Request for Information on direct-to-manufacturer prescription programs — neither of which targets octopamine as a pharmaceutical input or finished product. State and local procurement systems appear to have miscoded these opportunities; octopamine itself does not surface as an active procurement line item in the recent state or local competitive solicitation record.

The geographic spread cannot be meaningfully characterized beyond the two misaligned records: Seminole County, Florida (IFB60459723LAS, naloxone procurement, response deadline Jul 26, 2023) and Texas HHS Commission (RFI HHS0017013, direct-to-manufacturer prescription program, response deadline Apr 3, 2026). With no verified state or local opportunities actually soliciting octopamine products or services, the code appears inactive for practical procurement purposes at the state and local level. Business development professionals should treat this code as dormant unless future opportunities surface with accurate commodity classifications.